These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17083980

  • 1. A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase.
    Kage KL, Richardson PL, Traphagen L, Severin J, Pereda-Lopez A, Lubben T, Davis-Taber R, Vos MH, Bartley D, Walter K, Harlan J, Solomon L, Warrior U, Holzman TF, Faltynek C, Surowy CS, Scott VE.
    J Neurosci Methods; 2007 Mar 30; 161(1):47-54. PubMed ID: 17083980
    [Abstract] [Full Text] [Related]

  • 2. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening.
    Ramarao MK, Murphy EA, Shen MW, Wang Y, Bushell KN, Huang N, Pan N, Williams C, Clark JD.
    Anal Biochem; 2005 Aug 01; 343(1):143-51. PubMed ID: 16018870
    [Abstract] [Full Text] [Related]

  • 3. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
    Wang Y, Ramirez F, Krishnamurthy G, Gilbert A, Kadakia N, Xu J, Kalgaonkar G, Ramarao MK, Edris W, Rogers KE, Jones PG.
    J Biomol Screen; 2006 Aug 01; 11(5):519-27. PubMed ID: 16760367
    [Abstract] [Full Text] [Related]

  • 4. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
    Zhang D, Saraf A, Kolasa T, Bhatia P, Zheng GZ, Patel M, Lannoye GS, Richardson P, Stewart A, Rogers JC, Brioni JD, Surowy CS.
    Neuropharmacology; 2007 Mar 01; 52(4):1095-105. PubMed ID: 17217969
    [Abstract] [Full Text] [Related]

  • 5. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F, Nguyen MT, Emerling DE, Kelly MG, Duncton MA.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6793-6. PubMed ID: 19850474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing.
    Doehring A, Geisslinger G, Lötsch J.
    Prostaglandins Other Lipid Mediat; 2007 Nov 01; 84(3-4):128-37. PubMed ID: 17991615
    [Abstract] [Full Text] [Related]

  • 9. A fluorescent assay suitable for inhibitor screening and vanin tissue quantification.
    Ruan BH, Cole DC, Wu P, Quazi A, Page K, Wright JF, Huang N, Stock JR, Nocka K, Aulabaugh A, Krykbaev R, Fitz LJ, Wolfman NM, Fleming ML.
    Anal Biochem; 2010 Apr 15; 399(2):284-92. PubMed ID: 20018163
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
    Myllymäki MJ, Saario SM, Kataja AO, Castillo-Melendez JA, Nevalainen T, Juvonen RO, Järvinen T, Koskinen AM.
    J Med Chem; 2007 Aug 23; 50(17):4236-42. PubMed ID: 17665899
    [Abstract] [Full Text] [Related]

  • 11. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
    Fezza F, De Simone C, Amadio D, Maccarrone M.
    Subcell Biochem; 2008 Aug 23; 49():101-32. PubMed ID: 18751909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
    Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, Piomelli D.
    J Med Chem; 2004 Oct 07; 47(21):4998-5008. PubMed ID: 15456244
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V.
    Int Rev Neurobiol; 2009 Oct 07; 85():57-72. PubMed ID: 19607961
    [Abstract] [Full Text] [Related]

  • 18. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
    Meyers MJ, Long SA, Pelc MJ, Wang JL, Bowen SJ, Schweitzer BA, Wilcox MV, McDonald J, Smith SE, Foltin S, Rumsey J, Yang YS, Walker MC, Kamtekar S, Beidler D, Thorarensen A.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6545-53. PubMed ID: 21924613
    [Abstract] [Full Text] [Related]

  • 19. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage.
    Trabucco E, Acone G, Marenna A, Pierantoni R, Cacciola G, Chioccarelli T, Mackie K, Fasano S, Colacurci N, Meccariello R, Cobellis G, Cobellis L.
    Placenta; 2009 Jun 01; 30(6):516-22. PubMed ID: 19419760
    [Abstract] [Full Text] [Related]

  • 20. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 01; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.